Literature DB >> 14689700

Neutralization and antibody-dependent enhancement of dengue viruses.

Scott B Halstead1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14689700     DOI： 10.1016/s0065-3527(03)60011-4

Source DB:  PubMed          Journal:  Adv Virus Res        ISSN： 0065-3527            Impact factor:   9.937


× No keyword cloud information.
  299 in total

1.  B-cell responses during primary and secondary dengue virus infections in humans.

Authors:  Anuja Mathew; Kim West; Siripen Kalayanarooj; Robert V Gibbons; Anon Srikiatkhachorn; Sharone Green; Daniel Libraty; Smita Jaiswal; Alan L Rothman
Journal:  J Infect Dis       Date:  2011-09-19       Impact factor: 5.226

2.  Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo.

Authors:  Katherine L Williams; Wahala M P B Wahala; Susana Orozco; Aravinda M de Silva; Eva Harris
Journal:  Virology       Date:  2012-04-25       Impact factor: 3.616

Review 3.  Staphylococcus aureus pneumonia and dengue virus co-infection and review of implications of coinfection.

Authors:  Rajeev Peeyush Nagassar; Roma Jaanki Bridgelal-Nagassar; Nathlee McMorris; Nathalie Mc Morris; Karen Judith Roye-Green
Journal:  BMJ Case Rep       Date:  2012-07-03

4.  Characteristic of dengue disease in Taiwan: 2002-2007.

Authors:  Chien-Chou Lin; Yh-Hsiung Huang; Pei-Yun Shu; Ho-Sheng Wu; Yee-Shin Lin; Trai-Ming Yeh; Hsiao-Sheng Liu; Ching-Chuan Liu; Huan-Yao Lei
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

5.  Dengue virus: Bumps in the road to therapeutic antibodies.

Authors:  Leslie Goo; Theodore C Pierson
Journal:  Nature       Date:  2015-08-20       Impact factor: 49.962

6.  Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope.

Authors:  Feng Long; Michael Doyle; Estefania Fernandez; Andrew S Miller; Thomas Klose; Madhumati Sevvana; Aubrey Bryan; Edgar Davidson; Benjamin J Doranz; Richard J Kuhn; Michael S Diamond; James E Crowe; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-14       Impact factor: 11.205

7.  Prospective study to determine accuracy of rapid serological assays for diagnosis of acute dengue virus infection in Laos.

Authors:  Stuart D Blacksell; David Bell; James Kelley; Mammen P Mammen; Robert V Gibbons; Richard G Jarman; David W Vaughn; Kemajittra Jenjaroen; Ananda Nisalak; Soulignasack Thongpaseuth; Manivanh Vongsouvath; Viengmone Davong; Phonelavanh Phouminh; Rattanaphone Phetsouvanh; Nicholas P J Day; Paul N Newton
Journal:  Clin Vaccine Immunol       Date:  2007-08-22

Review 8.  Zika virus vaccines: immune response, current status, and future challenges.

Authors:  Justin M Richner; Michael S Diamond
Journal:  Curr Opin Immunol       Date:  2018-05-10       Impact factor: 7.486

9.  A mouse monoclonal antibody against dengue virus type 1 Mochizuki strain targeting envelope protein domain II and displaying strongly neutralizing but not enhancing activity.

Authors:  Atsushi Yamanaka; Tomohiro Kotaki; Eiji Konishi
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

10.  Dengue virus evolution and virulence models.

Authors:  Rebeca Rico-Hesse
Journal:  Clin Infect Dis       Date:  2007-04-18       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.